Escalon Medical Corp (ESMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -309 | 116 | 2,742 | 2,183 | 1,444 |
| Depreciation Amortization | 189 | 92 | 242 | 187 | 128 |
| Accounts receivable | -219 | -552 | -128 | 339 | 326 |
| Other Working Capital | -1,504 | -2,172 | 180 | 394 | 39 |
| Other Operating Activity | 255 | 581 | 128 | -339 | -326 |
| Operating Cash Flow | $-1,588 | $-1,935 | $3,163 | $2,764 | $1,611 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77 | -40 | -68 | -42 | -37 |
| Net Acquisitions | -868 | 295 | -231 | N/A | N/A |
| Purchase Of Investment | -193 | -130 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,138 | $126 | $-299 | $-42 | $-37 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,901 | N/A | 154 | 154 | 154 |
| Debt Repayment | 0 | -4,259 | -1,615 | -1,200 | -784 |
| Common Stock Issued | 30 | N/A | 11,780 | 11,821 | 59 |
| Other Financing Activity | -4,305 | -669 | -879 | -879 | -879 |
| Financing Cash Flow | $-6,176 | $-4,928 | $9,440 | $9,896 | $-1,450 |
| Exchange Rate Effect | 7 | -3 | N/A | N/A | N/A |
| Beginning Cash Position | 12,602 | 12,602 | 298 | 298 | 298 |
| End Cash Position | 3,707 | 5,862 | 12,602 | 12,916 | 423 |
| Net Cash Flow | $-8,895 | $-6,740 | $12,304 | $12,618 | $124 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,588 | -1,935 | 3,163 | 2,764 | 1,611 |
| Capital Expenditure | -77 | -40 | -68 | -42 | -37 |
| Free Cash Flow | -1,665 | -1,975 | 3,095 | 2,722 | 1,574 |